Get started
Author

Pierre Gestraud

The Influence of Feature Selection Methods on Accuracy, Stability and Interpretability of Molecular Signatures
2011 · Anne-Claire Haury, Pierre Gestraud, et al. · PLoS ONE · 416
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen
2019 · Michael P. Menden, Dennis Wang, et al. · Nature Communications · 371
PDF
A druggable copper-signalling pathway that drives inflammation
2023 · Stéphanie Solier, Sebastian Müller, et al. · Nature · 351
PDF
Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells
2008 · Bérengère Marty, Virginie Maire, et al. · Breast Cancer Research · 224
PDF
Independent Component Analysis Uncovers the Landscape of the Bladder Tumor Transcriptome and Reveals Insights into Luminal and Basal Subtypes
2014 · Anne Biton, Isabelle Bernard-Pierrot, et al. · Cell Reports · 216
PDF
Molecular profiling of patient-derived breast cancer xenografts
2012 · Fabien Reyal, Charlotte Guyader, et al. · Breast Cancer Research · 205
PDF
Genomics to select treatment for patients with metastatic breast cancer
2022 · Fabrice Andre, Thomas Filleron, et al. · Nature · 170
Multi-factor data normalization enables the detection of copy number aberrations in amplicon sequencing data
2014 · Valentina Boeva, Tatiana Popova, et al. · Bioinformatics · 135
PDF
Human chromosome‐specific aneuploidy is influenced by DNA‐dependent centromeric features
2019 · Marie Dumont, Riccardo Gamba, et al. · The EMBO Journal · 134
PDF
Bioinformatics for precision medicine in oncology: principles and application to the SHIVA clinical trial
2014 · Nicolas Servant, Julien Roméjon, et al. · Frontiers in Genetics · 93
PDF
In vivo genome-wide CRISPR screens identify SOCS1 as intrinsic checkpoint of CD4 + T H 1 cell response
2021 · Aurélien Sutra Del Galy, Silvia Menegatti, et al. · Science Immunology · 79
PDF
Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trial
2014 · C Le Tourneau, X Paoletti, et al. · British Journal of Cancer · 77
PDF
Cdc42 controls the dilation of the exocytotic fusion pore by regulating membrane tension
2014 · Marine Bretou, Ouardane Jouannot, et al. · Molecular Biology of the Cell · 76
Histo‐genomic stratification reveals the frequent amplification/overexpression of CCNE 1 and BRD 4 genes in non‐BRCAness high grade ovarian carcinoma
2015 · Oumou Goundiam, Pierre Gestraud, et al. · International Journal of Cancer · 64
PDF
EMA - A R package for Easy Microarray data analysis
2010 · Nicolas Servant, Eleonore Gravier, et al. · BMC Research Notes · 63
PDF
Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome
2019 · Suzy Scholl, Marina Popovic, et al. · EBioMedicine · 53
PDF
Targeting CCR5 trafficking to inhibit HIV-1 infection
2019 · Gaelle Boncompain, Floriane Herit, et al. · Science Advances · 36
PDF
Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
2023 · Elizabeth R. Tucker, Irene Jiménez, et al. · Clinical Cancer Research · 35
PDF
A catalog of numerical centrosome defects in epithelial ovarian cancers
2022 · Jean‐Philippe Morretton, Anthony Simon, et al. · EMBO Molecular Medicine · 34
PDF
DNA methylation restricts coordinated germline and neural fates in embryonic stem cell differentiation
2024 · Mathieu Schulz, Aurélie Teissandier, et al. · Nature Structural & Molecular Biology · 32
PDF
RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia
2022 · Justine Decroocq, Rudy Birsen, et al. · Leukemia · 30
PDF
Telomere crisis in kidney epithelial cells promotes the acquisition of a microRNA signature retrieved in aggressive renal cell carcinomas
2013 · Luis Jaime Castro-Vega, Karina Jouravleva, et al. · Carcinogenesis · 28
Enhancing Abiraterone Acetate Efficacy in Androgen Receptor–positive Triple-negative Breast Cancer: Chk1 as a Potential Target
2018 · Thomas Grellety, Celine Callens, et al. · Clinical Cancer Research · 26
Fine‐needle aspiration as an alternative to core needle biopsy for tumour molecular profiling in precision oncology: prospective comparative study of next‐generation sequencing in cancer patients included in the SHIVA02 trial
2020 · Célia Dupain, Julien Masliah‐Planchon, et al. · Molecular Oncology · 24
PDF
Genetic markers and phosphoprotein forms of beta-catenin pβ-Cat552 and pβ-Cat675 are prognostic biomarkers of cervical cancer
2020 · Suzy M Scholl, Jonas Beal, et al. · EBioMedicine · 11
PDF
Works count: 116
Citation count: 3,064
H-index: 24
I10-index: 26
Year
Topic
Type